This announcement is a separate document:
オンコリスバイオファーマ：第三者割当による第20回新株予約権（行使価額修正条項付及び行使停止条項付）の発行及び新株予約権の買取契約（コミット・イシュー）の締結に関するお知らせ
Oncolys BioPharma: Announcements of individual stocks regarding the issuance of the 20th subscription rights by third-party allocation (with modification clause for exercise price and suspension clause for exercise) and the conclusion of the purchase agreement (commitment issue) of subscription rights.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated